One of the world’s largest pharmaceutical companies has never listed. A case study in self-funded research, animal health as a cash engine and the real cost of independence.
Startup · Topic
Chemicals, Pharma & Life Sciences
Expert guides, analysis and tool comparisons on Chemicals, Pharma & Life Sciences from the kurums.com Startup desk — written for business decision-makers and updated as the market moves.
- 5 guides
- Updated Aug 4, 2026
Latest in Chemicals, Pharma & Life Sciences
Merck KGaA: The 350-Year-Old Family Company That Listed Without Losing Control
Merck is listed, 350 years old and still family-controlled through a partnership structure that makes takeover impossible. A case study in control, capital and its costs.
BioNTech: What a Mainz Biotech Did With a Once-in-a-Generation Windfall
BioNTech burned capital for a decade, then earned tens of billions in eighteen months. A case study in platform strategy, partnership design and German capital market gaps.
Bayer and Monsanto: Anatomy of the Worst Acquisition in German History
Bayer’s $63bn Monsanto acquisition destroyed most of its market value through litigation it underwrote incorrectly. A case study in due diligence, tail risk and legal jurisdiction.
BASF: Can the Verbund Model Survive European Energy Prices?
BASF built the world’s most integrated chemical site, and European gas prices turned its greatest advantage into a structural cost problem. A case study in industrial relocation.
All guides
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.